Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1122461

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the level of care and support available for women with breast cancer in (a) Merseyside, (b) North West England and (c) England in each of the last five years.
	tabling member constituency	Liverpool, West Derby
	tabling member printed	Stephen Twigg
	uin	246436
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>The National Cancer Programme is committed to ensuring, where appropriate, every person diagnosed with cancer, including breast cancer, will have access to personalised care, including a needs assessment, a care plan and health and wellbeing information by 2021. This involves assessing the trends in the level of care and support available for all cancer patients, including breast cancer, at a Cancer Alliance level.</p><p>Cheshire and Merseyside Cancer Alliance have achieved full implementation of personalised stratified follow up for breast cancer patients, which includes supported self-management, holistic needs assessments, care planning and health and wellbeing information. Cheshire and Merseyside Cancer Alliance are also looking to improve personalised follow up for all cancers, including breast cancer, such as improving access to psychological care and access to care for, and prevention of, other consequences of treatment. The provision of support and care in the area covered by the Alliance has significantly improved (Alliance level results from the National Cancer Patients Experience Survey (2018)). Cancer patients in Cheshire and Merseyside rate their overall care as 8.9/10, with 92% reporting that they had access to a Clinical Nurse Specialist. For breast cancer patients, 98% of patients reported having access to a Clinical Nurse Specialist, and their overall rating of care was 9.1/10.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 01/05/2019 15:17:43 answering member 4455 label Biography information for Seema Kennedy
	tabling member	167 label Biography information for Stephen Twigg

1122466

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Opioids: Misuse
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress Public Health England has made on its pledge to review the use of the phrase discontinuation syndrome as a means of describing opioid dependence.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	246461
	answer	answer is ministerial correction date of answer 29/04/2019 answer text <p>Public Health England (PHE) has not used the term ‘discontinuation syndrome’ to refer to opioid dependence. The term was used in the early stages of the Prescribed Medicines Review in relation to antidepressant medication as that was the only term recognised by some stakeholders at the time the review started.</p><p>PHE did agree to review the use of the term and has done so. It persists in some older review documents but is not being included in current documents. Information and documents on the review are published at the following link:</p><p><a href="https://www.gov.uk/government/collections/prescribed-medicines-an-evidence-review" target="_blank">https://www.gov.uk/government/collections/prescribed-medicines-an-evidence-review</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 29/04/2019 14:30:48 answering member 4455 label Biography information for Seema Kennedy
	tabling member	534 label Biography information for Chris Ruane

1122471

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how he plans to fund prescriptions for Continuous Glucose Monitoring devices following their addition to the high-cost tariff-excluded devices list for 2019-20.
	tabling member constituency	Knowsley
	tabling member printed	Mr George Howarth
	uin	246458
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>The information requested on the number of prescriptions that have been issued for continuous glucose monitoring devices in each clinical commissioning group (CCG) area in not collected. CCGs are responsible for commissioning and funding diabetes services, including funding for prescriptions for continuous glucose monitoring devices, for their local populations. CCGs are clinically led organisations that have both the local knowledge and accountability to make commissioning and funding decisions in the best interests of their patients.</p><p>CCGs and providers should agree a local price for when these devices are in use, as they are not set by the national tariff but are in the high cost devices list in the tariff for 2019/20.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246459 question first answered 01/05/2019 15:59:56 answering member 4455 label Biography information for Seema Kennedy
	tabling member	481 label Biography information for Sir George Howarth

1122475

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prescriptions have been issued for Continuous Glucose Monitoring devices in each clinical commissioning group area in (a) each year since 2015 and (b) 2019.
	tabling member constituency	Knowsley
	tabling member printed	Mr George Howarth
	uin	246459
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>The information requested on the number of prescriptions that have been issued for continuous glucose monitoring devices in each clinical commissioning group (CCG) area in not collected. CCGs are responsible for commissioning and funding diabetes services, including funding for prescriptions for continuous glucose monitoring devices, for their local populations. CCGs are clinically led organisations that have both the local knowledge and accountability to make commissioning and funding decisions in the best interests of their patients.</p><p>CCGs and providers should agree a local price for when these devices are in use, as they are not set by the national tariff but are in the high cost devices list in the tariff for 2019/20.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246458 question first answered 01/05/2019 15:59:56 answering member 4455 label Biography information for Seema Kennedy
	tabling member	481 label Biography information for Sir George Howarth

1122479

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the implications for his policies of findings from Teenage Cancer Trust and Public Health England which show significant variation in the incidence and survival rate of cancer among 13 to 24 year olds based on geography and deprivation.
	tabling member constituency	Alyn and Deeside
	tabling member printed	Mark Tami
	uin	246466
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>As part of the work undertaken to review national service specifications for Teenagers and Young Adult (TYA) cancer services, NHS England worked closely with Public Health England and the Teenage Cancer Trust to review current public health data, this included the data underpinning the following report:</p><p><a href="https://www.teenagecancertrust.org/sites/default/files/13-24%20year%20olds%20with%20cancer%20in%20England%20-%20incidence%20mortality%20survival%20FINAL%20%28Jan%202019%29.pdf" target="_blank">https://www.teenagecancertrust.org/sites/default/files/13-24%20year%20olds%20with%20cancer%20in%20England%20-%20incidence%20mortality%20survival%20FINAL%20%28Jan%202019%29.pdf</a></p><p>A public consultation will commence shortly over NHS England’s proposals to drive improvement in TYA cancer services. These include empowering local TYA Cancer Principal Treatment Centres to drive network-wide service improvement in both outcomes and experience and working in close partnership with TYA Designated Hospitals as part of a network. This approach will allow local flexibility to put in place solutions that are tailored to local needs. Further detail will be available on publication of the consultation guide.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246496 question first answered 01/05/2019 15:24:20 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1383 label Biography information for Mark Tami

1122495

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chickenpox: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of vaccinating against chickenpox.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	246480
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>In 2010, after carefully considering all the available evidence, the Joint Committee on Vaccination and Immunisation (JCVI) found that offering a universal varicella vaccination programme against chickenpox would not be cost effective and may increase the risk of severe disease and complications in adulthood, both from chickenpox and shingles. The JCVI statement is available at the following link:</p><p><a href="http://webarchive.nationalarchives.gov.uk/20120907090205/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_133599.pdf" target="_blank">http://webarchive.nationalarchives.gov.uk/20120907090205/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_133599.pdf</a></p><p> </p><p>The JCVI keeps all its recommendations under review and is currently considering the latest scientific evidence to establish whether a routine childhood varicella vaccination programme would be effective and of benefit in England; this includes evidence from other countries that have introduced a vaccination programme. The JCVI will make its recommendations, once it has considered all the necessary evidence.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 01/05/2019 15:40:15 answering member 4455 label Biography information for Seema Kennedy
	tabling member	1436 label Biography information for Paul Farrelly

1122497

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Labelling
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s public consultation entitled Calorie labelling for food and drink served outside of the home, which closed on 7 December 2018, how many responses the consultation received; and if he will commit to publish a response to that consultation before the next Parliamentary recess.
	tabling member constituency	Newcastle upon Tyne North
	tabling member printed	Catherine McKinnell
	uin	246524
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>The consultation on mandating calorie labelling in the out-of-home sector received a high level of interest with over 1,000 responses from members of the public, businesses and organisations. We will publish the results and set out the timetable for further action later this year.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 14:01:10 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4125 label Biography information for Catherine McKinnell

1122505

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pregnancy: Sodium Valproate
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the NICE guideline for epilepsy on sodium valproate as first-line treatment for children, young people and adults with newly diagnosed juvenile myoclonic epilepsy is compatible with the Medicines and Healthcare Products Regulatory Agency pregnancy prevention programme.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	246540
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the wording of its guideline recommendations. NICE has advised that it will ensure that its recommendations on the use of sodium valproate are consistent with the regulatory position, as set out by the Medicines and Healthcare products Regulatory Agency. The two organisations are working closely together to ensure that this is the case.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 01/05/2019 15:28:32 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4436 label Biography information for Cat Smith

1122543

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Spinal Injuries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of delays in discharges from NHS Spinal Cord Injury Centres on patients awaiting treatment; and what steps his Department has taken to reduce those delays.
	tabling member constituency	Tooting
	tabling member printed	Dr Rosena Allin-Khan
	uin	246564
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>NHS England is aware of the benefits of timely admission to a Spinal Cord Injury Centre (SCIC). A key aim of the Spinal Cord Injury Review is to produce a service that is able to offer each newly injured patient prompt admission to a SCIC.</p><p>We are currently working with the existing eight centres to develop a network model that will allow the sharing of best practice and improve standardisation of high quality care. This would include learning from the experiences of centres that currently have the lowest waiting times for admission. The network would also enable the co-ordination of the actions of referring hospitals and their awareness of the referral processes to SCI centres and ensure they are supported with information and specialist advice about how best to look after cord injured patients prior to admission.</p><p>There is also work underway looking at options to increase SCI care provision to meet unmet demand across the eight centres, with the possibility of a new unit to serve the population that currently has limited access to a SCI centre. Any new SCI unit would need to be co-located with a major trauma centre.</p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 01/05/2019 15:35:17 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1122544

	registered interest
	date	23/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's polices of the findings of Teenage Cancer Trust and Public Health England, that there are significant variations of incidence and survival rates of cancer in 13 to 24 year olds based on geography and deprivation.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	246496
	answer	answer is ministerial correction date of answer 01/05/2019 answer text <p>As part of the work undertaken to review national service specifications for Teenagers and Young Adult (TYA) cancer services, NHS England worked closely with Public Health England and the Teenage Cancer Trust to review current public health data, this included the data underpinning the following report:</p><p><a href="https://www.teenagecancertrust.org/sites/default/files/13-24%20year%20olds%20with%20cancer%20in%20England%20-%20incidence%20mortality%20survival%20FINAL%20%28Jan%202019%29.pdf" target="_blank">https://www.teenagecancertrust.org/sites/default/files/13-24%20year%20olds%20with%20cancer%20in%20England%20-%20incidence%20mortality%20survival%20FINAL%20%28Jan%202019%29.pdf</a></p><p>A public consultation will commence shortly over NHS England’s proposals to drive improvement in TYA cancer services. These include empowering local TYA Cancer Principal Treatment Centres to drive network-wide service improvement in both outcomes and experience and working in close partnership with TYA Designated Hospitals as part of a network. This approach will allow local flexibility to put in place solutions that are tailored to local needs. Further detail will be available on publication of the consultation guide.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 246466 question first answered 01/05/2019 15:24:20 answering member 4455 label Biography information for Seema Kennedy
	tabling member	3960 label Biography information for Henry Smith